GlassScriptPhysician profile
Sharad Bajaj
NPI 1497917512
$4,139.79
in general payments reported to CMS, 2019-2025
29 companies · $973 in 2025
The $973 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $348 · 2022: $864 · 2023: $469 · 2024: $1,486 · 2025: $973.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,927.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,927.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $743.68 | 2021-2024 | Xarelto |
| Boston Scientific Corporation | $566.18 | 2024-2025 | General - Tachy, Resonate El Icd Vr, Avvigo Guidance System |
| Pfizer INC. | $469.93 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $249.09 | 2022 | |
| Angiodynamics, INC. | $224.99 | 2024-2025 | Auryon Laser System 100-120 Vac |
| Impulse Dynamics (USA) INC. | $203.75 | 2022-2025 | Optimizer |
| Amgen INC. | $201.22 | 2023-2025 | Repatha, Repatha |
| Sonex Health, INC. | $166.66 | 2025 | Sx-One Microknife |
| Inari Medical, INC. | $134.24 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Merck Sharp & Dohme LLC | $125.54 | 2022-2025 | Verquvo |
| Cvrx, INC. | $125.42 | 2024 | Barostim Neo System |
| Medtronic, INC. | $109.64 | 2021-2025 | Onyx Frontier |
| Cook Medical LLC | $101.52 | 2025 | Icast Covered Stent System, 6mmx22mmx120cm, Zilver Ptx, Zilver Vena |
| E.R. Squibb & Sons, L.L.C. | $95.51 | 2024-2025 | Camzyos, Eliquis |
| Atricure, INC. | $83.03 | 2023-2024 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $68.50 | 2024-2025 | Impella |
| Penumbra, INC. | $57.25 | 2024-2025 | Indigo System, Penumbra System |
| Philips North America LLC | $55.00 | 2024-2025 | (Ck4) Mcot, Ecc Solutions |
| Actelion Pharmaceuticals US, INC. | $52.89 | 2024 | Opsumit, Uptravi |
| Novartis Pharmaceuticals Corporation | $47.35 | 2022-2024 | |
| Esperion Therapeutics, INC. | $45.92 | 2022-2023 | Nexletol |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $38.56 | 2022-2025 | Lifevest |
| Terumo Medical Corporation | $34.97 | 2023-2024 | Glidewire |
| Cardiovascular Systems INC. | $30.44 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $28.95 | 2021-2022 | |
| Abbott Laboratories | $28.37 | 2025 | Aveir |
| United Therapeutics Corporation | $21.95 | 2025 | Tyvaso |
| Lexicon Pharmaceuticals, INC. | $15.19 | 2023 | Inpefa |
| Novo Nordisk INC | $14.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharad Bajaj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.